DE69328114T2 - Peptide als diagnose- und therapiemittel für spondyloarthropathien - Google Patents

Peptide als diagnose- und therapiemittel für spondyloarthropathien

Info

Publication number
DE69328114T2
DE69328114T2 DE69328114T DE69328114T DE69328114T2 DE 69328114 T2 DE69328114 T2 DE 69328114T2 DE 69328114 T DE69328114 T DE 69328114T DE 69328114 T DE69328114 T DE 69328114T DE 69328114 T2 DE69328114 T2 DE 69328114T2
Authority
DE
Germany
Prior art keywords
hla
proteins
peptides
peptide
gram negative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69328114T
Other languages
English (en)
Other versions
DE69328114D1 (en
Inventor
Hal Scofield
B Harley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oklahoma Medical Research Foundation
Original Assignee
Oklahoma Medical Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oklahoma Medical Research Foundation filed Critical Oklahoma Medical Research Foundation
Application granted granted Critical
Publication of DE69328114D1 publication Critical patent/DE69328114D1/de
Publication of DE69328114T2 publication Critical patent/DE69328114T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70539—MHC-molecules, e.g. HLA-molecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
DE69328114T 1992-08-31 1993-08-31 Peptide als diagnose- und therapiemittel für spondyloarthropathien Expired - Fee Related DE69328114T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/944,143 US5719064A (en) 1992-08-31 1992-08-31 Peptide diagnostics and therapeutics for spondyloarthropathies
PCT/US1993/008214 WO1994005303A1 (en) 1992-08-31 1993-08-31 Peptide diagnostics and therapeutics for spondyloarthropathies

Publications (2)

Publication Number Publication Date
DE69328114D1 DE69328114D1 (en) 2000-04-20
DE69328114T2 true DE69328114T2 (de) 2000-09-28

Family

ID=25480875

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69328114T Expired - Fee Related DE69328114T2 (de) 1992-08-31 1993-08-31 Peptide als diagnose- und therapiemittel für spondyloarthropathien

Country Status (9)

Country Link
US (1) US5719064A (de)
EP (1) EP0667781B1 (de)
AT (1) ATE190491T1 (de)
AU (1) AU5124993A (de)
CA (1) CA2143322C (de)
DE (1) DE69328114T2 (de)
DK (1) DK0667781T3 (de)
ES (1) ES2145061T3 (de)
WO (1) WO1994005303A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5874531A (en) 1995-03-07 1999-02-23 President And Fellows Of Harvard College Identification of self and non-self antigens implicated autoimmune disease
EP0950065B1 (de) * 1996-09-18 2003-02-19 Gerhild Wildner Peptide als diagnostikum und therapeutikum für autoimmunerkrankungen
FR2758821B1 (fr) * 1997-01-30 1999-04-16 Centre Nat Rech Scient Utilisation d'un polypeptide a titre de recepteur cellulaire des adenovirus
FR2758822B1 (fr) * 1997-01-30 1999-07-02 Centre Nat Rech Scient Utilisation d'un polypeptide a titre de recepteur cellulaire des adenovirus
GB9715177D0 (en) * 1997-07-21 1997-09-24 Neutec Pharma Plc Medicament
DE69940805D1 (de) 1998-01-31 2009-06-10 Sinai School Medicine Verfahren und reagenzien zur verminderung der klinischen reaktion zur allergie
US7100685B2 (en) * 2000-10-02 2006-09-05 Enventure Global Technology Mono-diameter wellbore casing
US6908899B2 (en) * 2001-08-17 2005-06-21 U.S. Dept. Of Veterans Affairs Pro-inflammatory fibrinopeptide
US7084247B2 (en) 2004-03-11 2006-08-01 Peptimmune, Inc. Identification of self and non-self antigens implicated in autoimmune diseases

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL85746A (en) * 1988-03-15 1994-05-30 Yeda Res & Dev Preparations comprising t-lymphocyte cells treated with 8-methoxypsoralen or cell membranes separated therefrom for preventing or treating autoimmune diseases
JPH05500653A (ja) * 1989-05-31 1993-02-12 スクリプス　クリニック　アンド　リサーチ　ファウンデーション リウマチ様関節炎の処置法

Also Published As

Publication number Publication date
ATE190491T1 (de) 2000-04-15
DK0667781T3 (da) 2000-06-05
CA2143322C (en) 1998-05-26
DE69328114D1 (en) 2000-04-20
EP0667781B1 (de) 2000-03-15
WO1994005303A1 (en) 1994-03-17
CA2143322A1 (en) 1994-03-17
ES2145061T3 (es) 2000-07-01
US5719064A (en) 1998-02-17
AU5124993A (en) 1994-03-29
EP0667781A4 (de) 1997-07-16
EP0667781A1 (de) 1995-08-23

Similar Documents

Publication Publication Date Title
Clegg et al. Haemoglobin Icaria, a new chain-termination mutant which causes α thalassaemia
ATE133681T1 (de) Mykobakterielle rekombinanten und peptide
ATE183514T1 (de) Peptide des menschlichen proteins p53 zum gebrauch in menschlichen-zytotoxischen-t-zell- antwort-induzierenden kompositionen sowie menschliche p53-protein-spezifische t-lymphocyten
RU94045919A (ru) Антитела, клетки, полипептид, днк векторы, способ получения полипептида, способ получения антитела, фармацевтическая композиция
CA2256308A1 (en) Antibodies to the ed-b domain of fibronectin, their construction and uses
DE262192T1 (de) Verfahren und mittel zur herstellung eines proteins mit dergleichen igg-spezifizitaet wie protein g.
Strong et al. Isolation, characterization and synthesis of peptides from human fibrinogen that block the staphylococcal clumping reaction and construction of a synthetic clumping particle
ATE260295T1 (de) Peptidfragmente von mikrobiellen stressproteinen und daraus hergestellte pharmazeutische zusammensetzungen für die behandlung und vorbeugung von entzündungserkrankungen
ATE380867T1 (de) Lactoferrinrezeptorgen von moraxella
DE69328114T2 (de) Peptide als diagnose- und therapiemittel für spondyloarthropathien
DE69434839D1 (de) Transferrin-rezeptor gene von haemophilus
PT97355A (pt) Processo para a preparacao de polipeptidos recombinantes contendo uma sequencia de aminoacidos de uma proteina de celulas
Kirschbaum et al. A unique proteolytic fragment of human fibrinogen containing the A alpha COOH-terminal domain of the native molecule.
ATE197403T1 (de) Methoden zur detektion und behandlung von individuen mit abnormalen hla-a2/tyrosinase- peptidantigenen exprimierenden zellen
Seon et al. Monoclonal IgA and IgM in the Serum of a Single Patient (SC) II. Identity of Light Chains from IgA (κ) and IgM (κ)
Roos et al. Determination of the epitope of an inhibitory antibody to proliferating cell nuclear antigen
Lazure et al. Sequence diversity within a subgroup of mouse immunoglobulin kappa chains controlled by the IgK-Ef2 locus.
Murano et al. Primary structure of the amino terminal regions of chicken fibrin chains
SE9901601D0 (sv) Peptides from the TT virus sequence and monospecific antibodies binding to the TT virus
SHINODA Amino Acid Sequence of a Human Kappa Type Bence-Jones Protein: II. Chymotryptic Peptides and Sequence of Protein Ni
Franklin et al. Correlation of protein structure and immunoglobulin gene organization in the light of two new deleted heavy chain disease proteins
Schilling et al. Analysis of the diversity of murine antibodies to dextran B1355: N-terminal amino acid sequences of heavy chains from serum antibody
HK1060594A1 (en) Isolated peptides which bind to hla-c molecules and uses thereof
NO962596L (no) Nytt tumorsupressorgen
Sparrow et al. Amino acid sequences of wool keratin IF proteins

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee